EPISODE · Feb 7, 2022 · 29 MIN
Episode 232: Managing MS and Comorbidities with Dr. Ruth Ann Marrie
from RealTalk MS · host Jon Strum and Dr. Ruth Ann Marrie
Research shows that about 50% of the people living with MS will develop another chronic health condition, or comorbidity, in their lifetime. Whether it's high blood pressure, diabetes, or something else, living with comorbid conditions adds extra challenges to living with MS. Joining me to discuss how comorbidities affect people living with MS and what you can do to avoid developing some of those comorbidities is one of the leading experts on the subject, Dr. Ruth Ann Marrie. We're also talking about why a Phase 2 clinical trial for a prospective MS disease-modifying therapy got a do-over. We'll share some very encouraging news about how the enrollment for a new study turned out. We'll also share results from a study in the U.K. that remind us why everyone living with MS needs to be vaccinated and boosted. We'll give you the registration info for this year's series of First Descents (no cost!) outdoor adventures for young adults living with MS. And we'll tell you how to register for the National MS Society's virtual 2022 Public Policy Conference. We have a lot to talk about! Are you ready for RealTalk MS??! GeNeuro completes Phase 2 clinical trial for Temelimab -- again! 1:29 The CONNECT study connects with all the right participants 3:56 U.K. study results provide one more reason for everyone with MS to be vaccinated 5:57 Registration is now open for First Descents outdoor adventures for young adults living with MS 7:56 MS Society opens registration for this year's virtual Public Policy Conference 9:32 Dr. Ruth Ann Marrie discusses comorbidities and MS 11:56 Share this episode 28:10 Download the RealTalk MS app for your iOS or Android device 28:30 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/232 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected] Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com National MS Society COVID-19 Vaccine Guidance for People Living with MS https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance National MS Society Third COVID-19 Vaccine Dose Guidance for People Living with MS https://www.nationalmssociety.org/About-the-Society/News/Additional-COVID-19-Vaccine-Dose-(Booster)-and-MS National MS Society Public Policy Conference Registration https://nmss.6connex.com/event/PPC/login STUDY: Recovery from COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register https://nn.neurology.org/content/9/1/e1118 First Descents Program Information https://firstdescents.org/programs/ms-programs/ Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 232 Guests: Dr. Ruth Ann Marrie Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy
NOW PLAYING
Episode 232: Managing MS and Comorbidities with Dr. Ruth Ann Marrie
No transcript for this episode yet
Similar Episodes
Jun 13, 2026 ·41m
Jun 12, 2026 ·41m
Jun 11, 2026 ·41m
Jun 11, 2026 ·43m
Jun 10, 2026 ·42m
Jun 9, 2026 ·55m